Found: 9
Select item for more details and to access through your institution.
Rozlytrek Approved for Solid Tumors with NTRK Gene Fusion and for Metastatic ROS1-Positive NSCLC.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 9, p. 22
- Publication type:
- Article
FDA Approves Nubeqa for Nonmetastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 9, p. 22
- Publication type:
- Article
Gilteritinib and CX-01 in the Treatment of Patients with Acute Myeloid Leukemia.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 9, p. 19
- By:
- Publication type:
- Article
Enfortumab Vedotin Promising Third-Line Option for Metastatic Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 9, p. 16
- By:
- Publication type:
- Article
Reduced-Intensity Chemotherapy for Frail Elderly Patients with Advanced Gastroesophageal Cancer.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 9, p. 15
- By:
- Publication type:
- Article
Combination Immune Blockade Promising in High-Grade Neuroendocrine Tumors: The DART "Basket" Clinical Trial.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 9, p. 11
- By:
- Publication type:
- Article
Applying CAR T-Cell Therapies to Solid Tumors: Overcoming Current Challenges.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 9, p. 1
- By:
- Publication type:
- Article
Repotrectinib, an Investigational TKI, Induces Response in ROS1-Fusion'Positive NSCLC.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 9, p. 1
- By:
- Publication type:
- Article
National Oncology State Network: Making a Difference.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 9, p. 1
- By:
- Publication type:
- Article